# A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of BWC0977 in Healthy Volunteers

> **NCT05088421** · PHASE1 · COMPLETED · sponsor: **Bugworks Research Inc.** · enrollment: 44 (actual)

## Conditions studied

- Infectious Diseases
- Bacterial Infections

## Interventions

- **DRUG:** BWC0977
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05088421
- **Lead sponsor:** Bugworks Research Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-05
- **Primary completion:** 2022-12-29
- **Final completion:** 2023-05-28
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2023-07-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05088421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05088421, "A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of BWC0977 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05088421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*